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Background: The transfer of multiple embryos after in vitro fertilization (IVF) increases the risk of twins and higher-
order births. Multiple births are associated with significant health risks and maternal and neonatal complications, as
well as physical, emotional, and financial stresses that can strain families and increase the incidence of depression
and anxiety disorders in parents. Elective single embryo transfer (eSET) is among the most effective methods to
reduce the risk of multiple births with IVF.
Main body: Current societal guidelines recommend eSET for patients <35 years of age with a good prognosis,
yet even this approach is not widely applied. Many patients and clinicians have been reluctant to adopt eSET
due to studies reporting higher live birth rates with the transfer of two or more embryos rather than eSET.
Additional barriers to eSET include risk of treatment dropout after embryo transfer failure, patient preference for
twins, a lack of knowledge about the risks and complications associated with multiple births, and the high
costs of multiple IVF cycles. This review provides a comprehensive summary of strategies to increase the rate of
eSET, including personalized counseling, access to educational information regarding the risks of multiple
pregnancies and births, financial incentives, and tools to help predict the chances of IVF success. The use of
comprehensive chromosomal screening to improve embryo selection has been shown to improve eSET
outcomes and may increase acceptance of eSET.
Conclusions: eSET is an effective method for reducing multiple pregnancies resulting from IVF. Although
several factors may impede the adoption of eSET, there are a number of strategies and tools that may
encourage the more widespread adoption of eSET in clinical practice.
Keywords: Elective single embryo transfer, Assisted reproductive technologies, Patient education,
Comprehensive chromosomal screening, Multiple birthsBackground
Elective single embryo transfer (eSET) is the transfer of
a single cleavage- or blastocyst-stage embryo after
in vitro fertilization (IVF) or intracytoplasmic sperm in-
jection (ICSI), despite the availability of more than one
good-quality embryo [1]. Transfer of multiple embryos
incurs an increased risk of twins or higher-order births,
which can be associated with a variety of maternal and
neonatal risks [2–4]. eSET is among the most effective
methods to reduce the risk of multiple births with IVF [1].
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cians in determining appropriate numbers of embryos to
transfer and identifying those patients most appropriate
for eSET [2, 4]. The guidelines currently recommend
eSET for most patients aged <35 years with a good
prognosis (Table 1) [2]. Although the chance of suc-
cessful delivery declines with increasing age, patients
of advanced age are still at risk for multiples and
should be considered for eSET if they have top-quality
embryos [2]; however, patients aged ≥35 years are not
routinely offered SET [1, 5].
Although SET rates have been increasing in the United
States, they still lag significantly behind the rest of the
world [1, 6]. In Europe, 27.5 % of all transfers in 2011
were SET [7], compared with rates in the United States
of 17 % in 2011 and 24 % in 2013 [5, 8]. SET isle is distributed under the terms of the Creative Commons Attribution 4.0
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Table 1 ASRM/SART recommended criteria for eSET [1]
• Women aged <35 years
− Women aged 35–40 years should also consider eSET if they have
top-quality blastocyst-stage embryos available for transfer
• More than one top-quality embryo available for transfer
− Blastocyst-stage embryos are preferred
• First or second IVF cycle
• Previously successful IVF cycle
• Recipients of embryos from donated eggs
ASRM, American Society for Reproductive Medicine; SART, Society for Assisted
Reproductive Technology; eSET, elective single embryo transfer; IVF, in vitro
fertilization
Fig. 1 Live birth rates with SET and multiple embryo transfer [5].
Percentages of live births that were singletons, twins, and triplets or
higher-order births are shown in parentheses. Percentages may not
total 100.0 % due to rounding. In rare cases, a single embryo may
divide and produce twins. For this reason, a small percentage of
twins resulted from SET, and a small percentage of triplets resulted
from DET. SET, single embryo transfer; DET, double embryo transfer
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countries, and these policies have been shown to dra-
matically reduce the number of twin and higher-order
births [1, 7, 9]. Implementation of a national SET
policy in Sweden reduced the rate of twin births with
IVF by 17 % without compromising outcomes (pregnancy
rates were 33 % before and 37 % after SET legislation) [9].
Results from a survey of 170 fertility clinics in the United
States showed that the majority (94 %) of respondents
reported adhering to the ASRM transfer guidelines.
However, 35 % also reported that they routinely
transfer two embryos in patients <35 years of age
with a good prognosis [10], a surprising disconnect.
Moreover, half of the clinics indicated that they deviate
from recommended guidelines in response to patient pref-
erences. In 2013, the mean number of embryos trans-
ferred in fresh cycles in the United States was 1.8 for
women <35 years of age and 1.9 for women 35 to 37 years
of age, implying most centers still transfer two embryos in
good-prognosis patients [5].
A number of factors are thought to impede the wide-
spread uptake of eSET in the United States, including a
perceived lower overall success rate when compared
with double embryo transfer (DET); lack of patient edu-
cation regarding the risks associated with multiples; and
high dropout rate following failed cycles due to financial,
emotional, and/or physical burden. Improving patient
education and support is essential to encouraging the
adoption of eSET, and predictive models and enhanced
embryo selection can help to empower patients to
choose eSET while maintaining high success rates. This
review summarizes the benefits of eSET, obstacles to the
adoption of eSET, and strategies to increase eSET
rates to achieve the optimal outcome of infertility
treatment—a healthy singleton birth.
Outcomes with single versus multiple embryo transfer
In the United States, the twin birth rate has increased by
more than 75 % since 1980, mainly due to the use of
assisted reproductive technology (ART) [3, 4]. The inci-
dence of twin births is more than 20 times greater withpregnancies resulting from ART compared with naturally
conceived pregnancies [4]. When comparing live birth
rates for a single cycle with SET versus DET, the overall
birth rate is higher with DET (a difference of 7 %);
however, the proportion of multiple births is also sub-
stantially higher with DET (Fig. 1) [5, 11]. Results from a
prospective, randomized trial in women aged <38 years
with a good prognosis demonstrated that cumulative live
birth rates with eSET followed by transfer of a single
frozen embryo (45 %) were similar to those seen with a
single DET cycle (42 %), whereas the rates of multiple
births were 0 versus 28 %, respectively [12]. These find-
ings are consistent with other studies [13–17] and sug-
gest that initial eSET plus subsequent frozen eSET is as
effective as DET while preventing the risks associated
with multiple pregnancy.
Impact of singleton versus multiple births
While medical advances have improved the outcomes of
multiple births, these births are still associated with sig-
nificant complications and health risks for both the
mother and infants [3, 4]. Multiple birth parents also
face increased financial and psychosocial stresses that
can persist long after the newborn stage [3]. The med-
ical, financial, and psychological effects of multiple preg-
nancy and birth on the mother and family are
summarized in Table 2 and described below.
Maternal and infant health risks
A retrospective registry study comparing the outcomes
of women undergoing two singleton pregnancies after
IVF (n = 921) with those of women undergoing one twin
Table 2 Summary of the impacts of multiple pregnancy [3, 4, 18, 19, 21–26]











− Twin-to-twin transfusion syndrome
• Spontaneous abortion
• Intrauterine growth restriction
• Preterm (<37 weeks), very preterm (<32 weeks),
and extreme preterm (<28 weeks) birth
• Perinatal and infant mortality
• Low (<2500 g) and very low birth weight (<1500 g)
• Intraventricular hemorrhage
• Periventricular leukomalacia






• Retinopathy of prematurity
• Cerebral palsy
• Neural tube defects, heart malformations, and other
birth defects
• Developmental delays
• Postpartum depression (mother and father)
• Relationship stress
• Financial stress
− Obstetric costs and neonatal intensive
care admission
− Costs for caring for multiple children
throughout childhood
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maternal outcomes were dramatically better in those
undergoing two singleton pregnancies [18]. Indeed, mul-
tiple gestations increase the risk for nearly every recog-
nized obstetric complication. Some of the significant
maternal complications of multiple pregnancy include
preeclampsia, gestational diabetes, placenta previa, pla-
cental abruption, and requirement for cesarean delivery
[4, 18]. Twins and higher-order multiples are at greater
risk for fetal growth restriction, preterm delivery, and
low birth weight [4, 18, 19]. In 2013, >50 % of twins
and >90 % of triplets in the United States were born pre-
term and/or had a low birth weight, compared with <10 %
of singletons [20]. Preterm birth is associated with an in-
creased risk of severe complications, including intraven-
tricular hemorrhage, respiratory distress syndrome,
necrotizing enterocolitis, sepsis, jaundice, and neonatal
mortality [4, 18, 19]. Multiple births are also associated
with an increased risk of longer-term complications, such
as congenital heart defects, cerebral palsy, developmental
delays, and learning disabilities [18, 21].
Financial considerations
The adverse medical outcomes associated with multiple
births translate into significantly increased healthcare
costs, particularly during infancy [22]. Estimated infant
and maternal healthcare costs of twin pregnancies are
three to five times higher than those of singleton preg-
nancies, while higher-order multiples cost approximately
20 times more than singletons [22, 23]. The increased
healthcare costs of multiple births are due, in part, to
complications during labor and delivery, requirement for
cesarean delivery, longer duration of hospital stay, and
increased admission to the neonatal intensive care unit(NICU) [23]. The increased need for/duration of bed
rest during multiple pregnancies may also result in tem-
porary loss of income [3], and these data are often not
included in cost analyses of multiple gestations. Add-
itionally, multiple births are associated with a variety of
increased non-healthcare costs, including childcare for
multiple children (or loss of income if a parent decides
to stay at home), and additional costs for food, clothing,
diapers, car seats, furniture/housing, schooling, and
other essentials throughout childhood [3].
Psychosocial impacts
Physical, emotional, and financial stresses can increase
the incidence of depression and anxiety disorders in par-
ents rearing multiples [3, 24]. A survey of mothers rais-
ing children conceived through ART found that multiple
births were associated with decreased quality of life and
increased stress, depression, and social stigma [24]. Post-
partum depression is also more common in parents of
multiples and may be long term [3]. Studies have add-
itionally reported that parents of multiples are more
likely to experience decreased marital satisfaction [24]
and to divorce or become separated compared with par-
ents of singletons [25, 26]. A retrospective study in the
United Kingdom also found that families with twins or
triplets were more likely to be financially worse off after
the births, to experience difficult or very difficult finan-
cial stress, to not have the mother return to work within
9 months after the birth, and to have children with de-
layed or very delayed school readiness [26].
Barriers to eSET
Patient requests for multiple embryo transfer may repre-
sent the greatest challenge to the adoption of eSET as a
Fig. 2 Patient preferences for eSET or DET in scenarios with varying
pregnancy rates [32]. eSET, elective single embryo transfer; DET,
double embryo transfer
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bryo transfer decision, including nulliparity, family
income, level of knowledge regarding the risks of multi-
ples, patient age, duration of infertility, and the desire to
limit the physical and psychological stress of multiple
IVF cycles [27–29].
Many patients express a preference for siblings, or
even twins, and thus may be more willing to accept the
risks associated with multiple pregnancy [28, 29]. A sur-
vey of 449 infertile women found that one in five listed
multiple birth as their most desired outcome [28].
Avoidance of multiple births was indicated as less im-
portant than treatment efficacy, safety, affordability, and
time to conception; patients who desired multiple births
also demonstrated a greater lack of knowledge regarding
the potential risks and complications associated with
multiple births [28]. Thus, patients may truly desire a
live birth and be less concerned, given lack of know-
ledge, how that perceived optimal outcome is achieved.
For many infertile patients, the desire to become preg-
nant may outweigh concerns regarding the adverse out-
comes of multiple births and the realities of raising
multiple children, particularly given the increasing soci-
etal acceptance of multiples and their generally positive
portrayal in the media [27, 30]. Women may be con-
cerned that increasing age will limit their opportunities
to have children. A study of 79 women undergoing IVF
found that age was significantly correlated with embryo
transfer preferences, with older women generally prefer-
ring to transfer multiple embryos [27]. A separate study
found that patients with longer duration of infertility
(≥2 years) were more likely to desire multiple births
[28]. Infertile couples may want to maximize their
chances for a successful outcome and consequently may
be unwilling to accept a lower pregnancy rate to prevent
a twin pregnancy [31]. Results from a study involving
244 women assessing the attitudes toward eSET versus
DET in scenarios with various pregnancy rates demon-
strated that when IVF/ICSI pregnancy rates were low-
ered by just 1–5 % after eSET, the proportion of patients
preferring eSET decreased; in the scenario where eSET
was as effective as DET, more than 50 % of patients still
preferred DET over eSET (Fig. 2) [32]. All scenarios de-
scribed a twin pregnancy rate of 25 % after DET versus
1 % after eSET. Additionally, patients who desire more
than one child may want to attempt to complete their
family in as few cycles as possible to avoid the emotional
and psychological stress of further treatment [29].
Additional challenges to adopting eSET are the high
out-of-pocket costs associated with IVF and limited in-
surance coverage for most patients in the United States
[31]. A recent Canadian study found that just 1 year of
universal IVF coverage increased eSET rates by 30 %
and reduced multiple pregnancy by 23 % [33]. Similarly,implementation of an Australian healthcare program
providing public funding for partial reimbursement of
ART (including unlimited IVF cycles) resulted in an in-
crease in eSET cycles from 29.5 to 68 % over a 6-year
period [34]. In the United States, insurance coverage for
IVF is also associated with fewer embryos transferred
and a lower rate of multiple births; however, few states
currently offer coverage for IVF [28, 35, 36].
Strategies for increasing the eSET rate
Increasing eSET rates will have a large impact on redu-
cing multiple births and should be encouraged early and
consistently during treatment in good-prognosis patients
[31]. It should be stressed that the goal of infertility
treatment should be the delivery of a healthy single baby,
with fewer twin and higher-order births. A multi-faceted
approach incorporating patient education and counsel-
ing, reimbursement offers or other financial incentives,
and IVF success prediction tools can be used to improve
eSET rates in clinical practice (Fig. 3) [37–40].
Patient education and decision aids
Educational materials reviewing eSET and the risks and
complications associated with multiple births can help
patients make an informed decision on the number of
embryos to transfer. Decision aids come in many forms,
including written materials (e.g., fact sheets and bro-
chures), websites, videos, interactive tools, and patient
testimonials [38]. A randomized study in 222 infertile
couples reported that the majority of patients appreci-
ated the use of a decision aid and felt it helped them to
decide how many embryos to transfer [38]. A New
Zealand study showed that the rate of eSET tripled 1 year
after the initiation of a patient education program
providing materials that outlined the benefits of eSET
and risks associated with DET [41]. A separate study
Fig. 3 Strategies to increase acceptance of eSET [37–40]. eSET, elective single embryo transfer. IVF, in vitro fertilization; PR, pregnancy rate; ET,
embryo transfer
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on eSET rate and found that, after receiving the educa-
tion materials, couples preferred eSET over DET, even
among those who had previously preferred DET [39].
Counseling and advice from physicians and nurses
It is important for the entire team (physicians, nurses,
embryologists, and other clinical staff ) to be aligned with
respect to eSET recommendations so that a clear, con-
sistent message is provided to all patients. Nurses should
objectively discuss the content of decision aids, clarify
questions, and enable couples to make an informed deci-
sion [38]. A randomized study in 222 infertile couples
showed that the physician’s advice and counseling by an
IVF nurse were among the most influential factors driv-
ing a patient’s decision of how many embryos to transfer
[38]. Investigators felt nurse counseling was important
because nurses provided more individualized support for
their patient’s particular physical, emotional, and social
situation [38]. Nurses, in particular, can provide patients
with tools to cope with the emotional burden of multiple
ART cycles [42]. Approximately 70 % of patients also ap-
preciated a follow-up phone call just prior to oocyte re-
trieval to discuss any relevant questions that might have
arisen during IVF treatment.
Financial incentives
In the United States, insurance coverage for ART is
mandated in only 15 states [36]. Reimbursement offers
and financial incentives provided by fertility clinics or in-
surance companies may thus help relieve financial con-
straints that limit the number of cycles a patient can
undergo and thereby influence a patient’s decision on
how many embryos to transfer. Data from an ongoingpilot study evaluating the use of financial incentives
(>$5000 in savings) to increase eSET rates in the United
States showed that the majority of patients (60 %) agreed
to eSET; the 40 % of couples who declined eSET did so
because they desired twins [43]. Of note, the clinical and
ongoing pregnancy rates were similar among patients in
the eSET and DET groups; however, the rates of twin
births were 2 and 30 %, respectively.
Several countries have implemented public funding or
insurance programs that provide full or partial reim-
bursement of ART costs, sometimes contingent upon
the transfer of a single or limited number of embryos.
These programs have been associated with increases in
the utilization of ART, live births following ART treat-
ments, and the proportion of eSET or SET cycles, and a
decrease in the rate of multiple births [34, 44–46]. These
trends are observed regardless of whether SET is man-
dated or just encouraged.
Prediction tools
Information from online prediction tools that estimate
the chances of IVF success based on individual patient
characteristics can be used to help counsel patients
[47–49]. Currently, patients can access several com-
mercially available online prediction tools or a free on-
line IVF predictor tool developed by SART. These
tools incorporate a number of prognostic factors, such
as a patient’s age, demographic information, health
and medical history, and IVF response data, into a
prediction model without considering data about em-
bryo development, stage, and quality [40, 47, 49]. Pre-
diction tools can be up to 1000 times more accurate
in predicting a patient’s chance of successful outcome than
simple age-based estimates [48], while also predicting the
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can complement personalized counseling in helping pa-
tients make decisions about whether and when to start
IVF/ICSI procedures versus alternatives, such as intrauter-
ine insemination or the use of donor eggs. Prediction tools
can also help infertility center staff identify patients at
greater risk for multiple births (e.g., probability >25 %)
who should receive more extensive eSET counseling to
minimize the risk of multiple gestation and associated
complications.
Genetic screening
Preimplantation genetic screening (PGS), including com-
prehensive chromosomal screening (CCS) technologies,
allows clinicians to assess embryos for aneuploidy (i.e.,
an abnormal number of chromosomes) prior to transfer
[50]. Aneuploidy accounts for the majority (~70 %) of
miscarriages in both natural and ART-conceived preg-
nancies [51]. Most patients undergoing IVF have at least
one or two embryos available for biopsy, which involves
removing a small number of cells for genetic testing. In
a retrospective analysis of more than 15,000 embryos,
the incidence of a patient having no normal (euploid)
embryos was low for patients <40 years of age [50].
Trophectoderm biopsy at the blastocyst stage (Day 5
and/or 6) is currently the preferred method for screening
[52], as it has, to date, not been shown to negatively
impact implantation and pregnancy outcomes [50, 53].
The development of 24-chromosome CCS techniques,
which currently include array comparative genomic
hybridization (aCGH), quantitative real-time polymerase
chain reaction (qPCR), single nucleotide polymorphism
(SNP) array, and next-generation sequencing (NGS), has
greatly improved the ability to detect aneuploid embryos
[54]. In contrast with older methods (i.e., fluorescence inFig. 4 Impact of CCS and eSET on (a) delivery rates and (b) multiple births
screening; eSET, elective single embryo transfer; IVF, in vitro fertilizationsitu hybridization), these techniques allow for the ana-
lysis of all 24 chromosomes [54]. In a recent global sur-
vey of 386 IVF clinics where 342,000 cycles have been
performed, aCGH was indicated as the preferred PGS
method by 59 % of clinics, and NGS was indicated as
the preferred method by 16 % [52].
CCS is highly predictive of the reproductive potential
of human embryos. Data from two prospective studies
demonstrated that 96 % of embryos predicted to be an-
euploid by CCS failed to sustain implantation compared
with 41 % of embryos predicted to be euploid [55]. Re-
cent meta-analyses also found that CCS increased im-
plantation and pregnancy rates [56, 57]. Furthermore,
use of CCS changes the selection of embryos for transfer
compared with traditional morphology criteria, leading
to the observed improvement in pregnancy and delivery
outcomes [57, 58]. A separate randomized control study
in 175 patients who were <43 years of age and undergo-
ing IVF demonstrated that delivery rates were similar in
patients receiving eSET with one euploid blastocyst ver-
sus those receiving DET with untested blastocysts (69 vs
72 %), with elimination of multiple pregnancies in the
eSET group (Fig. 4) [59]. Euploid eSET was associated
with improved health outcomes, including lower risk of
preterm delivery and NICU admission, and reduced
costs compared with untested DET [59]. The use of CCS
may also improve SET outcomes in patients of ad-
vanced maternal age. Initial findings from a study in
patients aged >35 years showed that pregnancy rates
were higher in patients who underwent eSET with a
frozen euploid embryo compared with those who
underwent eSET with a fresh untested embryo (61 vs
41 %, respectively) [51]. It should be noted that both
fresh and frozen embryo transfers can be used in IVF
clinics following CCS [52].in patients undergoing IVF [59]. CCS, comprehensive chromosomal
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improved outcomes, patients may be more willing to
choose eSET if CCS options are utilized to guide embryo
selection. The previously mentioned global survey indi-
cated that 43 % of surveyed IVF clinics currently use
PGS in less than 10 % of cycles, with another 20 % of
clinics using PGS in just 10–20 % of cycles, although it
is suggested that a much higher proportion of patients
are considered eligible for PGS [52]. The low rate of
PGS use may be due in part to the requirement of pa-
tients to cover the costs out of pocket [52], although
these costs are more than offset by lower hospital costs
(through 28 days post-delivery) with euploid CCS eSET
versus untested DET, due to the elimination of multiple
births [60]. Additionally, as the technology evolves, the
costs for testing continue to decrease.
Mandatory SET policies and regulations
Several countries have developed policies and regula-
tions concerning the number of embryos transferred
during IVF cycles. In some countries, such as Sweden,
concerns over the high rate of multiple births led to gov-
ernment legislation limiting most patients to SET, with
the transfer of two or three embryos permitted only in
certain subpopulations [61]. Several other countries have
regulations on the number of transferred embryos that
are tied to insurance and public funding programs that
provide comprehensive or partial coverage for ART.
However, patients are not forced to adhere to these
regulations if they prefer to pay for ART themselves
[34, 44–46]. In Finland, there is no formal legislation
or requirement for SET, but IVF clinics together
elected to move towards an SET policy for most pa-
tients [62]. Regardless of the specific type of policy
set forth, retrospective studies comparing IVF out-
comes from before and after implementation of these
initiatives consistently demonstrate a sizeable decrease
in the rates of multiple pregnancies and multiple live
births (e.g., from 25 to 5 %) while maintaining steady
cumulative clinical pregnancy and live birth rates. A
Belgian study further showed that the cumulative de-
livery rate for patients’ first two cycles was lower after
introduction of a reimbursement/SET policy, but that
it had no statistically significant impact on the 6-cycle
cumulative delivery rate (65 % before vs 60 % after)
[45]. Initiation of the health program in Quebec was
also associated with a decrease of 35.5 % in prema-
ture live births and 37 % in the requirement for
NICU admission [44].
Currently there are no embryo transfer regulations in
the United States, although ASRM and SART have put
forth guidelines to assist centers in determining the ap-
propriate number of embryos for transfer in their pa-
tients [2, 4]. In some instances, individual IVF centershave chosen to develop mandatory SET policies for all
or certain subsets of their patients. If such a policy is put
in place, the center should ensure that it is clearly de-
scribed to all patients on their first visit and again
throughout the IVF cycle (e.g., prior to oocyte retrieval
and transfer) to help set and reinforce expectations.
One US clinic developed a mandatory SET policy for
all women <38 years of age without a history of failed
fresh cycle at their center, with ≥7 zygotes (2-pronuclei
stage) for culture, and ≥1 good- or excellent-quality
blastocyst available for transfer [63]. A retrospective ana-
lysis of all women <38 years of age undergoing a fresh
transfer at their center found that, in the 5 years follow-
ing implementation of the mandatory SET policy, the
overall live birth rate significantly improved from 51 to
56 % (P = 0.026) and the multiple birth rate decreased
from 35 to 17.5 % (P < 0.0001). Among the women who
underwent mandatory SET, the live birth rate was 66 %
(cumulative rate of 84 %) and the multiple birth rate was
3.4 %. Of note, implementation of the mandatory SET
policy did not affect overall clinical volume (2412 cycles
in the prior 5 years; 2389 cycles in the subsequent
5 years) [63]. A survey performed by the same US center
found that 94 % of all patients supported the mandatory
SET policy (including 69 % who strongly supported it)
[64]. Support for the policy did not vary by the number
of embryos transferred, but was stronger among patients
who felt they had the right amount of input into their
IVF treatment and embryo transfer decision, expressed
concerns about multiples, had extra embryos for cryo-
preservation, and/or had a shorter duration of infertility.
Conclusions
eSET is an effective method for reducing multiple preg-
nancies resulting from IVF and should be consistently
encouraged for the majority of patients to improve the
likelihood of delivering a healthy baby. There are many
factors that impede the adoption of eSET. Overall suc-
cess rates are lower per fresh cycle when compared with
the transfer of two or more embryos [8, 11, 13]. Patients
may not be willing to risk a failed cycle given the finan-
cial, emotional, and physical burden associated with IVF.
Furthermore, many patients desire twins and do not
fully consider the risks associated with twin pregnancies
and births [28, 29]. However, providing patients with
personalized counseling, access to educational informa-
tion regarding the risks of DET and multiple births, fi-
nancial incentives, tools to help predict the chances of
IVF success, and technologies to select high-quality em-
bryos for transfer should help to increase the use of
eSET in clinical practice.
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